Additionally, TMEM170B was found to be significantly downregulated in pancreatic adenocarcinoma (PAAD), breast cancer, ovarian cancer, and thyroid cancer (62). The gene discussed is TMEM170B; the disease is pancreatic adenocarcinoma.